Growing Ndds Market Driven by Targeted Drug Delivery
The Novel Drug Delivery Systems (NDDS) market is a rapidly growing segment of the pharmaceutical industry, with Factmr predicting it will continue to grow at a strong rate over the coming years. NDDS refers to a range of technologies and approaches that are designed to improve the delivery of drugs to their intended targets in the body, enhancing their efficacy and reducing side effects
The market is segmented by technology, route of administration, and application. Among the technologies, oral drug delivery systems held the largest market share in 2020, followed by parenteral drug delivery systems, transdermal drug delivery systems, and pulmonary drug delivery systems. The oral route of administration is preferred by patients due to ease of use, and the availability of various dosage forms such as tablets, capsules, and liquids.
Among the application areas, cancer held the largest market share in 2020, followed by cardiovascular diseases, diabetes, central nervous system disorders, and autoimmune disorders. The high prevalence of cancer and the need for targeted drug delivery to tumor sites are driving the growth of the NDDS market in this segment.
North America held the largest market share in 2020, followed by Europe, Asia Pacific, and the Rest of the World. The presence of well-established pharmaceutical companies and research institutions, favorable government policies, and high healthcare expenditure are some of the key factors driving the growth of the NDDS market in North America and Europe.
Overall, the NDDS market is expected to continue to grow at a strong rate in the coming years, driven by the increasing demand for targeted and personalized drug delivery and advancements in drug delivery technologies
Appreciate the creator